Tridacaine Iii Patch
Product Images NDC 73352-835

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tridacaine Iii (NDC 73352-835). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trifluent Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tridacaine 01)

Chemical structure diagram of lidocaine, the active ingredient in Tridacaine III topical patch 50 mg/g. The structure displays a benzene ring with two methyl groups, connected via an amide linkage to a side chain containing a nitrogen atom bonded to two ethyl groups.*

FDA Label Image

Figure 1 (Tridacaine 02)

A line graph illustrating plasma lidocaine concentration (ng/mL) over time (hours) up to 72 hours. The graph shows cyclical peaks and troughs in plasma levels, indicating fluctuating lidocaine concentrations over the time period.*

FDA Label Image

Principal Display Panel (15 Patch Pouch Label)

Label for Tridacaine III Lidocaine Patch 5% (50 mg/g) from Trifluent Pharma. The adhesive patch contains 700 mg of lidocaine USP in an aqueous base. The package includes 15 patches in 15 envelopes. Storage and warning information is provided, along with a barcode and distributor details from San Antonio, TX.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.